Company Summary: Kaya Holdings, Inc.

Business Focus

• Primary Focus Areas:
  • Wellness and mental health treatments via psychedelic therapy.
  • Operations in psychedelic treatment clinics, specifically licensed psilocybin clinics.
  • Medical and recreational cannabis production and retail.
  • CBD products and brands.

Key Developments

• Psychedelic Therapy:

  • Opened The Sacred Mushroom Psychedelic Treatment Center in Portland, Oregon, in September 2024.
  • First U.S. public company to own and operate a licensed psychedelics treatment facility.
  • Licensure received from Oregon Health Authority (OHA) in April 2024.
  • Treatment treatments began in September 2024.
  • Facility size: approximately 11,000 sq ft with private rooms, group areas, sensory zones, art expression, yoga, and activity zones.
  • Located in downtown Portland, with panoramic views of Mount Hood and city skyline.

• Cannabis Operations:

  • Over the past 10 years, operated multiple retail dispensaries under the Kaya Shack™ brand, including 4 in Oregon.
  • Licensed cultivation and processing facilities in Oregon.
  • Has a retail license in Oregon and licenses for cannabis production in Greece.
  • Marketed premium cannabis products including flower, oils, vape cartridges, and infused edibles.
  • Discontinued Oregon retail operations in mid-2024; only 1 licensed dispensary remains in Oregon, with operations halted due to strategic shift and financial constraints.

• International Cannabis Development:

  • Operates in Greece with medical cannabis licenses for cultivation and processing.
  • Joint ventures and investments in Greek cultivation sites with plans for large-scale operations.
  • Greek properties include Epidaurus and Thebes cultivation projects, totaling around 50,000 sq ft of constructed buildings.
  • Aims to export cannabis products across the EU, leveraging Greece’s favorable regulations.

• Legal and Regulatory Timeline:

  • Oregon was the first U.S. state to legalize psilocybin in November 2020.
  • Began accepting license applications for psilocybin facilitators in Oregon in January 2023.
  • Obtained facility license for The Sacred Mushroom in April 2024; operation started in September 2024.
  • Pending licenses and operational plans in Colorado, with activity aligned to its regulatory framework.

Financial and Operational Status

• Employees:

  • As of April 2025, only 2 full-time employees in Oregon:
    • Chad Craig, Senior Vice President of Oregon Operations.
    • Bryan Arnold, Vice President of Fifth Dimension Therapeutics and Lead Facilitator.
  • Engages part-time employees and independent contractors (licensed facilitators).

• Revenue and Income:

  • 2024 Revenue: approximately $7,134 from ongoing operations (primarily psychedelic treatments).
  • 2023 Revenue: $0 (no ongoing operations, only discontinued cannabis retail revenue).
  • Discontinued Cannabis Retail Revenue: $28,009 in 2024; $196,294 in 2023.
  • 2024 Net Loss: approximately $2,080,856 (mainly due to operating expenses, interest, debt amortization, and derivative liabilities).
  • 2023 Net Income: approximately $1,609,697.

• Operational Constraints:

  • Suspended payroll in April 2025 due to capital constraints.
  • Active efforts to restructure operations to increase revenues.
  • Capital raising via private placements, debt issuance, and strategic partnerships.

Strategic Goals

• Establish and expand licensed psychedelic treatment facilities.
• Become a leader in psychedelic “mind care” treatments, especially for mental health disorders resistant to traditional therapies.
• Leverage Oregon’s licensing framework for psilocybin therapy.
• Expand international cannabis cultivation and distribution in Greece and potentially other EU markets.
• Restructure and optimize operations financially and strategically to return to profitability.

Summary: Kaya Holdings, Inc. is a diversified health and wellness company with a core emphasis on licensed psychedelic psychedelic therapy, especially in Oregon, combined with a 10-year track record of cannabis production and retail operations. The company is currently transitioning from its cannabis retail roots toward establishing itself as a provider of legal, licensed psychedelic treatments, with a focus on mental health therapies using psilocybin.